148 related articles for article (PubMed ID: 15099321)
1. Follow-up of 1 mg finasteride treatment of male pattern baldness-difference between clinical trials and private office follow-up: influences on prescribing habits evaluated.
Rapaport MJ
Dermatol Surg; 2004 May; 30(5):761-3. PubMed ID: 15099321
[TBL] [Abstract][Full Text] [Related]
2. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
Finasteride Male Pattern Hair Loss Study Group
Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
Wolff H; Kunte C
MMW Fortschr Med; 1999 Sep; 141(37):38-40. PubMed ID: 10897972
[TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
Whiting DA
Eur J Dermatol; 2001; 11(4):332-4. PubMed ID: 11399540
[TBL] [Abstract][Full Text] [Related]
5. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
Price VH; Menefee E; Sanchez M; Kaufman KD
J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
[TBL] [Abstract][Full Text] [Related]
6. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
Whiting DA; Olsen EA; Savin R; Halper L; Rodgers A; Wang L; Hustad C; Palmisano J;
Eur J Dermatol; 2003; 13(2):150-60. PubMed ID: 12695131
[TBL] [Abstract][Full Text] [Related]
8. Finasteride in the treatment of Japanese men with male pattern hair loss.
Kawashima M; Hayashi N; Igarashi A; Kitahara H; Maeguchi M; Mizuno A; Murata Y; Nogita T; Toda K; Tsuboi R; Ueki R; Yamada M; Yamazaki M; Matsuda T; Natsumeda Y; Takahashi K; Harada S
Eur J Dermatol; 2004; 14(4):247-54. PubMed ID: 15319158
[TBL] [Abstract][Full Text] [Related]
9. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
Roberts JL; Fiedler V; Imperato-McGinley J; Whiting D; Olsen E; Shupack J; Stough D; DeVillez R; Rietschel R; Savin R; Bergfeld W; Swinehart J; Funicella T; Hordinsky M; Lowe N; Katz I; Lucky A; Drake L; Price VH; Weiss D; Whitmore E; Millikan L; Muller S; Gencheff C
J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
[TBL] [Abstract][Full Text] [Related]
10. Finasteride induced depression: a prospective study.
Rahimi-Ardabili B; Pourandarjani R; Habibollahi P; Mualeki A
BMC Clin Pharmacol; 2006 Oct; 6():7. PubMed ID: 17026771
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
Sato A; Takeda A
J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
[TBL] [Abstract][Full Text] [Related]
12. Male pattern baldness.
Hogan DJ; Chamberlain M
South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
[TBL] [Abstract][Full Text] [Related]
13. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
Kaufman KD; Rotonda J; Shah AK; Meehan AG
Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
[TBL] [Abstract][Full Text] [Related]
16. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
Shapiro J; Kaufman KD
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
[TBL] [Abstract][Full Text] [Related]
17. Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone.
Kohler C; Tschumi K; Bodmer C; Schneiter M; Birkhaeuser M
Gynecol Endocrinol; 2007 Mar; 23(3):142-5. PubMed ID: 17454167
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
Olsen EA
Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
[No Abstract] [Full Text] [Related]
19. Finasteride treatment of female pattern hair loss.
Iorizzo M; Vincenzi C; Voudouris S; Piraccini BM; Tosti A
Arch Dermatol; 2006 Mar; 142(3):298-302. PubMed ID: 16549704
[TBL] [Abstract][Full Text] [Related]
20. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
